Inscription Capital »

Anika Therapeutics shares owned by Inscription Capital

Quarter-by-quarter ownership of Anika Therapeutics (ANIK) shares owned by Inscription Capital from 13F filings

Historical chart of Inscription Capital investment in Anika Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Anika Therapeutics held by Inscription Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anika Therapeutics by Inscription Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $122k 13k 9.61

More positions owned by Inscription Capital

Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Spdr Series Trust State Street Spd (BIL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Pgim Etf Tr Pgim Ultra Sh Bd (PULS)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Wal-Mart Stores (WMT)
Chevron Corporation (CVX)
Nike CL B (NKE)

View all positions for Inscription Capital

Top funds holding Anika Therapeutics

BlackRock
Caligan Partners
Vanguard Group
Acadian Asset Management
Boothbay Fund Management
Renaissance Technologies
Capital Management Corporation
Dimensional Fund Advisors
State Street Corporation
Geode Capital Management
Jacobs Levy Equity Management
D. E. Shaw & Co
Trigran Investments
Goldman Sachs Group
Jane Street

View all funds holding Anika Therapeutics